Login / Signup

Trends in Late Mortality and Life Expectancy After Autologous Blood or Marrow Transplantation Over Three Decades: A BMTSS Report.

Smita BhatiaChen DaiWendy LandierLindsey HagemanJessica WuElizabeth SchlichtingArianna SilerErin FunkJessica HicksShawn LimNora BalasAlysia Kristine BosworthHok Sreng TeLiton FranciscoRavi BhatiaDonna SalzmanFrederick D GoldmanStephen J FormanDaniel J WeisdorfF Lennie WongSaro H ArmenianMukta Arora
Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Late mortality among autologous BMT recipients has declined over a 30-year period. However, ongoing efforts are needed to mitigate development of infections, subsequent neoplasms, and cardiovascular and renal disease to further reduce late mortality.
Keyphrases
  • cardiovascular events
  • cell therapy
  • risk factors
  • bone marrow
  • platelet rich plasma
  • cardiovascular disease
  • mesenchymal stem cells
  • quality improvement